Clinical Trials Directory

Trials / Completed

CompletedNCT04731545

Buccal Bone Resorption in Immediate SLActive Implant Placement Thin vs. Thick Buccal Bone

Evaluation of the Buccal Bone Resorption in Immediate SLActive Implant Placement in Thin vs. Thick Buccal Bone Plates: RCT

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Accepted

Summary

The utilization of SLActive implants which allow more rapid osseointgeration with 3 to 4 weeks. will be placed in thin buccal bone as immediate implants to determine the resorption compared to thick buccal bone

Detailed description

With the increased demand for aesthetics and the expectation of immediate tooth replacement, improving the treatment options in case with hopeless teeth in the esthetic zone by immediate implants is a need by both practitioners and patients. Current guidelines, today, restricting such treatment to only thick (+ or = 1mm) buccal bone plates. However, the literature shows that less than 10% of the community have such criteria, making it a high risk but needed procedure. Soft tissue and bone remodelling after extraction is an inescapable fact. Immediate implant placement cannot prevent soft tissue and bone remodeling around implants (Araújo et al. 2005, Chen et al. 2009), but implant surface treatment and modifications might enhance the maintainability of the supporting structures around the dental implant due to its faster integration, better stimulating the vascular components at the site. This could be tested by the crestal and buccal bone changes, pink esthetic score and ostell readings.

Conditions

Interventions

TypeNameDescription
DEVICEimmediate implant placementMinimally traumatic tooth extraction, immediate implant placement and hard tissue grafting. loading after 3 months.

Timeline

Start date
2017-01-15
Primary completion
2021-07-01
Completion
2022-06-01
First posted
2021-02-01
Last updated
2024-01-23

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04731545. Inclusion in this directory is not an endorsement.